| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC1114 |
| Trial ID | JPRN-jRCT1080225204 |
| Disease | Solid Tumor |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TAK-102 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Study of TAK-102 in Adult with Previously-Treated Solid Tumors |
| Year | 2020 |
| Country | Japan |
| Company sponsor | Takeda Pharmaceutical Company Limited |
| Other ID(s) | NCT04405778|JapicCTI-205300 |
| Cohort1: dose level 1 | |||||||
|
|||||||
| Cohort2: dose level 2 | |||||||
|
|||||||
| Cohort3: dose level 3 | |||||||
|
|||||||